Eleven Biotherapeutics (EBIO) Halted, News Pending
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Twitter (TWTR) Tops Q3 EPS by 4c; Announces Restructuring, Workforce Reduction
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Eleven Biotherapeutics (NASDAQ: EBIO) Halted, News Pending
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Gannett (GCI) -Tronc (TRNC) deal still in doubt as banks said to withdraw financing
- Aduro Biotech (ADRO), Inovio Pharma (INO), and Merchants Bancshares (MBVT) will resume trading at 8:30am ET
- tronc (TRNC) Halted on LUDP
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!